Preventive Vaccines Market is estimated to be US$ 69 billion by 2030 with a CAGR of 6.0% during the forecast period - By PMI

The report "Preventive Vaccines Market, By Vaccine Type (Live/Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vector Vaccines, and DNA Vaccines), By Disease Type (Pneumococcal, Poliovirus, Hepatitis, Influenza, Measles, Mumps and Rubella (MMR), Varicella, Human Papilloma Virus, and Other Disease Types), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Trends, Analysis and Forecast till 2030”

| Source: PMI PMI

Covina, April 10, 2023 (GLOBE NEWSWIRE) -- The Preventive Vaccine market accounted for US$ 39.45 Billion in 2020 and is estimated to be US$ 69.0 billion by 2030 and is anticipated to register a CAGR of 6.0%.The fact that vaccines were entirely responsible for the global eradication of smallpox (1980) and polio (2015), vaccine-preventable illnesses such as measles and mumps continue to be a concern. COVID-19 was just added to the list. In some disease sectors, such as polio, the preventive vaccinations industry has matured, whereas in others, it has yet to establish itself in the market. Infectious diseases are among the world's leading causes of death, posing some of the world's most serious health and security risks. Scientists from all over the world are now doing research, sharing information, increasing laboratory capacity in developing countries, and establishing global surveillance networks to prevent and control the spread of these diseases by preventive immunizations.

The report "Preventive Vaccines Market, By Vaccine Type (Live/Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vector Vaccines, and DNA Vaccines), By Disease Type (Pneumococcal, Poliovirus, Hepatitis, Influenza, Measles, Mumps and Rubella (MMR), Varicella, Human Papilloma Virus, and Other Disease Types),  and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Trends, Analysis and Forecast till 2030”

Key Highlights:

  • In January 2019, GSK and Medicines for Malaria Venture (MMV) announced the publication of positive results from two phase III studies of single- dose tafenoquine for the radical cure of Plasmodium Vivax (P. Vivax) Malaria in the New England Journal of Medicine.
  • In February 2018, GlaxosmithKline, PLC (GSK) RECEIVED European approval for the expanded indication for Fluarix Tetra (Influenza Vaccine) for ages 6 month to older.


Analyst View:
The rising prevalence of infectious diseases is a primary factor driving the target market’s growth. Vaccines now safeguard millions of people throughout the world from infectious diseases. In addition, infectious diseases are considered the world’s most lethal diseases, as well as the most serious health and security risks to the global population, and vaccines play a critical role in reducing the prevalence of infectious diseases. Such reasons are driving the demand for prophylactic vaccines around the world. The World Health Organization (WHO), for example, claims that immunization prevents 2-3 million deaths each year, and that they are confident that vaccines have saved millions of lives, but that estimating an exact number is hard.

Free PDF Download Now:

https://www.prophecymarketinsights.com/market_insight/Insight/request-pdf/3779

Scope of the Report:

  1. Market Preview
    • Executive Summary
    • Key Findings—Global Outlook for Preventive Vaccines  Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Vaccines type
      • Market Snippet, By Disease Type
      • Market Snippet, By Region
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  2. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  3. Global Preventive Vaccines  Market, By Vaccines type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Live/Attenuated Vaccines
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Inactivated Vaccines
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Subunit Vaccines
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Toxoid Vaccines
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Conjugate Vaccines
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Recombinant Vector Vaccines
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • DNA Vaccines
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  4. Global Preventive Vaccines  Market, By Disease Type, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Pneumococcal
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Poliovirus
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Hepatitis
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Influenza
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Measles
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Mumps and Rubella (MMR)
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Varicella, Human Papilloma Virus
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Other Disease Types
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030

Request Free Sample:
https://www.prophecymarketinsights.com/market_insight/Insight/request-sample/3779

Key Market Insights from the report:
The Global Preventive Vaccine market accounted for US$ 39.45 Billion in 2020 and is estimated to be US$ 69.0 billion by 2030 and is anticipated to register a CAGR of 6.0%.The Global Preventive Vaccine Market is segmented based on the vaccine type, disease type, and region. 

  • By Vaccine type, the Global Preventive Vaccine Market is segmented into Live/Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, Conjugate Vaccines, Recombinant Vector Vaccines, and DNA Vaccines.
  • By Disease type, the market is segmented in Pneumococcal, Poliovirus, Hepatitis, Influenza, Measles, Mumps and Rubella (MMR), Varicella, Human Papilloma Virus, and Other Disease Types.
  • By Region, the Global Preventive Vaccine Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America holds the largest share in the market, with the United States being the largest contributor to its revenue.

Competitive Landscape:

  • Astellas Pharma Inc
  • CSL Limited
  • Emergent BioSolutions
  • GlaxoSmithKline plc
  • Johnson & Johnson
  • MedImmune
  • Merck & Co
  • Pfizer
  • Sanofi Pasteur
  • Serum Institute of India Pvt. Ltd
  • Bavarian Nordic
  • Mitsubishi Tanabe Pharma Corporation
  • Daiichi Sankyo
  • Biological E
  • Panacea Biotec

The market provides detailed information regarding the industrial base, productivity, strengths, manufacturers, and recent trends which will help companies enlarge the businesses and promote financial growth. Furthermore, the report exhibits dynamic factors including segments, sub-segments, regional marketplaces, competition, dominant key players, and market forecasts. In addition, the market includes recent collaborations, mergers, acquisitions, and partnerships along with regulatory frameworks across different regions impacting the market trajectory. Recent technological advances and innovations influencing the global market are included in the report.

Some Important Points Answered in this Market Report Are Given Below:

  • Explains an overview of the product portfolio, including product development, planning, and positioning
  • Explains details about key operational strategies with a focus on R&D strategies, corporate structure, localization strategies, production capabilities, and financial performance of various companies.
  • Detailed analysis of the market revenue over the forecasted period.
  • Examining various outlooks of the market with the help of Porter’s five forces analysis, PEST & SWOT Analysis.
  • Study on the segments that are anticipated to dominate the market.
  • Study on the regional analysis that is expected to register the highest growth over the forecast period

Other related reports:

  1. Mono Vaccines: (Epstein-Barr virus) Market, By Age group (Adult, and Pediatrics), and By Region (North America, Europe, Asia Pacific, Latin America, Middle East, Africa) - Trends, Analysis and Forecast till 2029
  2. Disease Control and Prevention Vaccine Market: By Vaccine Type (Monovalent Vaccine and Multivalent Vaccine), Product Type (Live-attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, and Toxoid Vaccines), By Age Group (Pediatric, and Adults), By Application (Infectious Disease, Cancer, and Other Indication) and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Trends, Analysis and Forecast till 2029
  3. Travel Vaccines Market: By Composition (Mono Vaccines and Combination Vaccines), By Disease (Hepatitis A, DPT, Yellow Fever, Typhoid, Hepatitis B, Measles and Mumps, Rabies, Meningococcal, Varicella, Japanese Encephalitis, and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Trends, Analysis and Forecast till 2030
 

            








        

            

                

                    
Mot-clé

                            
                                Preventive Vaccines Market
                            
                            
                                Preventive Vaccines size
                            
                            
                                Preventive Vaccines overview
                            
                            
                                Preventive Vaccines trend
                            

                



        


    

        
Hyperliens

        
    



    

        

        
Coordonnées